日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD96 as a therapeutic target for CAR T cell therapy in acute myeloid leukemia

CD96 作为急性髓系白血病 CAR-T 细胞疗法的治疗靶点

Gao, Xiaotong; Liu, Hailing; Li, Guokun; Zhou, Yali; Dong, Yan; Chen, Xiao; Fan, Wen; Li, Erbing; Wang, Sanmei; Luan, Qinyao; Zhang, Jing; Jin, Hui; Liao, Hui; Luo, Yizhou; Liu, Li; Qin, Weiwei; Ren, Jiangtao; Li, Jianyong; Fan, Lei

Correction: Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma

更正:放射治疗后靶向 TIGIT 和 CD96 可提高头颈部鳞状细胞癌的免疫治疗疗效

Salah, Mohammed; Saito, Masafumi; Kawaguchi, Hiroki; Shimizu, Yasuyuki; Fujita, Yoshiko; Mukumoto, Naritoshi; Kotani, Joji; Shinomiya, Hirotaka; Ishihara, Takeaki; Miyawaki, Daisuke; Nibu, Nen-Ichi; Sasaki, Ryohei

HIV-1 manipulates CD96 on CD4+ T cells to subvert antiviral immunity

HIV-1通过操纵CD4+ T细胞上的CD96来逃避免疫反应。

Sandra Dehn ,Rabea Burkhard ,Johanna Leyens ,Tabea Kaiser ,Simone Brandimarte ,Dinah Heiligensetzer ,Herwig Koppensteiner ,Baubak Bajoghli ,Stephan Hailfinger ,Karin Schilbach ,Michael Schindler

Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma

放射治疗后靶向 TIGIT 和 CD96 可提高头颈部鳞状细胞癌的免疫治疗疗效

Salah, Mohammed; Saito, Masafumi; Kawaguchi, Hiroki; Shimizu, Yasuyuki; Fujita, Yoshiko; Mukumoto, Naritoshi; Kotani, Joji; Shinomiya, Hirotaka; Ishihara, Takeaki; Miyawaki, Daisuke; Nibu, Nen-Ichi; Sasaki, Ryohei

CD155-TIGIT/CD96/CD226 immune checkpoint axis interacting with tumor-infiltrating lymphocytes to exhibit diverse prognostic effects on breast cancer: a cohort study.

CD155-TIGIT/CD96/CD226 免疫检查点轴与肿瘤浸润淋巴细胞相互作用,对乳腺癌表现出不同的预后作用:一项队列研究。

Ou Xin, Yin Junyu, Shi Feng, Zhao Yanjie, Zhou Quan, Yuan Keyu, Lyu Shuzhen, Wu Jiangping, Li Yanping, Song Qingkun

Concurrent mutations in RNU4ATAC, PLEC, and CD96 in a child with severe short stature and skeletal dysplasia: a case report

一名患有严重矮小症和骨骼发育不良的儿童同时存在RNU4ATAC、PLEC和CD96基因突变:病例报告

Wang, Hui; Wang, Jinhui; Chen, Darong

Immunotherapeutic strategies targeting the PVR-TIGIT/CD96/CD226 signaling pathway in glioma treatment

针对胶质瘤治疗中 PVR-TIGIT/CD96/CD226 信号通路的免疫治疗策略

Qian, Da; Guo, Jiazheng; Duan, Yuchen; Zhou, Yibing; Wu, Chaoshen; Chen, Qun; Cai, Jinquan

T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis

T细胞衍生的白细胞介素-22驱动癌细胞表达CD155,从而抑制NK细胞功能并促进转移。

Daria Briukhovetska,Javier Suarez-Gosalvez,Cornelia Voigt,Anamarija Markota,Anastasios D Giannou,Maryam Schübel,Jakob Jobst,Tao Zhang,Janina Dörr,Florian Märkl,Lina Majed,Philipp Jie Müller,Peter May,Adrian Gottschlich,Nicholas Tokarew,Jöran Lücke,Arman Oner,Melanie Schwerdtfeger,David Andreu-Sanz,Ruth Grünmeier,Matthias Seifert,Stefanos Michaelides,Michael Hristov,Lars M König,Bruno Loureiro Cadilha,Oleg Mikhaylov,Hans-Joachim Anders,Simon Rothenfusser,Richard A Flavell,Daniela Cerezo-Wallis,Cristina Tejedo,María S Soengas,Tobias Bald,Samuel Huber,Stefan Endres,Sebastian Kobold

Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis

CD155-CD96免疫检查点缺陷控制巨细胞动脉炎中IL-9的产生

Shozo Ohtsuki ,Chenyao Wang ,Ryu Watanabe ,Hui Zhang ,Mitsuhiro Akiyama ,Melanie C Bois ,Joseph J Maleszewski ,Kenneth J Warrington ,Gerald J Berry ,Jörg J Goronzy ,Cornelia M Weyand

Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival

异基因造血干细胞移植后,CD8+ T细胞上CD94的早期表达和CD96的丢失可预测后续复发和生存率。

Verma, Kriti; Croft, Wayne; Pearce, Hayden; Zuo, Jianmin; Stephens, Christine; Nunnick, Jane; Kinsella, Francesca Am; Malladi, Ram; Moss, Paul